KDKartika Sari Dewi

Kartika Sari Dewi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kartika Sari Dewi has a total of 47 co-authors. Here are the top co-authors by number of shared publications:

  • Asrul Muhamad Fuad

    5 shared publications
  • Dian Fitria Agustiyanti

    Research Center for Genetic Engineering, Research Organization for Life Sciences and Environment, National Research and Innovation Agency (BRIN), Soekarno Science and Technology Park, Cibinong, Bogor, 16911, Indonesia

    3 shared publications
  • Fina Amreta Laksmi

    Affiliation Research Center for Applied Microbiology, National Research and Innovation Agency, Bogor, West Java, Indonesia

    3 shared publications
  • Isa Nuryana

    Research Center for Applied Microbiology, National Research and Innovation Agency, Jalan Raya Bogor KM 46, Cibinong, Bogor, West Java, 16911, Indonesia

    3 shared publications
  • Wien Kusharyoto

    Research Center for Genetic Engineering, Research Organization for Life Sciences and Environment, National Research and Innovation Agency (BRIN), Soekarno Science and Technology Park, Cibinong, Bogor, 16911, Indonesia

    3 shared publications
  • Aminah

    Research Centre for Biotechnology, Indonesian Institute of Sciences (LIPI), Cibinong Sciences Centre, Jalan Raya Bogor km. 46, Cibinong 16911, Bogor, Indonesia

    2 shared publications

Latest Publications

  • Soluble Expression of Recombinant Human Mitsugumin 53 in Escherichia coli NiCo21(DE3)

    by Kartika Sari Dewi, Winda Tasia, Dian Fitria Agustiyanti, Hariyatun Hariyatun, Popi Hadi Wisnuwardhani, Yana Rubiyana, Nissa Arifa, Hastuti Handayani Purba, Alfian Mahardika Forentin, Ratna Annisa Utami, et al.

  • High-level expression of codon-optimized Taq DNA polymerase under the control of rhaBAD promoter

    by Fina Amreta Laksmi, Kartika Sari Dewi, Isa Nuryana, Siti Eka Yulianti, Kharisma Panji Ramadhan, Moch Irfan Hadi, Yudhi Nugraha


  • Open Access

    Codon optimization of a gene encoding DNA polymerase from Pyrococcus furiosus and its expression in Escherichia coli

    by Isa Nuryana, Fina Amreta Laksmi, Kartika Sari Dewi, Faiz Raihan Akbar, Nurhayati, Rikno Harmoko


  • Open Access

    ANALISIS TERHADAP PENETAPAN DISPENSASI PERNIKAHAN DIBAWAH UMUR

    by Mutiara Jati Abdawiyah, Jeannery Cesare, Kartika Dewi, Dhiva Lefrysa, Hanik Maghfuroh, Safitri Mukarromah

    ABSTRAK Dispensasi nikah dibawah umur merupakan permohonan keringanan yang diberikan Pengadilan Agama kepada calon mempelai yang belum cukup umur untuk melangsungkan perkawinan. Berdasarkan Undang-Undang Nomor 16 Tahun 2019 tentang perkawinan, usia minimal untuk menikah adalah 19 tahun baik untuk pria maupun wanita. Penelitian ini bertujuan untuk mengetahui apa saja yang menjadi pertimbangan Hakim Pengadilan Agama Cilacap dalam memberikan penetapan pada perkara dispensasi nikah, serta apa yang menjadi hambatan ataupun kendala dalam proses penetapan dispensasi nikah. Jenis penelitian ini merupakan jenis penelitian lapangan dengan pendekatan kualitatif deskriptif. Sementara teknik pengumpulan data dilakukan dengan cara wawancara, observasi dam dokumentasi. Analisis data dilakukan dengan menggunakan teknik analisis yang bersifat induktif. Hasil penelitian menunjukkan bahwa pengajuan perkara dispensasi nikah di Pengadilan Agama Cilacap tergolong tinggi yaitu dilihat dari data tiga tahun terkahir yang jumlah pengajuan perkara dispensasi nikah mencapai 2232 perkara. Hakim dalam menjalankan persidangan dispensasi nikah berpedoman pada Undang- Undang Nomor 5 Tahun 2019 tentang Pedoman Mengadili Permohonan Dispensasi Nikah. Perkara dispensasi di Pengadilan Agama Cilacap menghasilkan penetapan yang menyatakan bahwa permohonan tersebut dikabulkan. Hal tersebut berdasarkan pertimbangan hakim, dimana hakim lebih mengutamakan kemaslahatan daripada kemudharatan, dimana apabila permohonan tidak dikabulkan dikhawatirkan akan menimbulkan kejadian yang tidak diinginkan, karena tidak dikabulkannya permohonan tidak menjamin para calon pengantin untuk berpisah. Kata Kunci; Penetapan Dispensasi Nikah Pengadilan Agama


  • Expression of Codon-Optimized Gene Encoding Murine Moloney Leukemia Virus Reverse Transcriptase in Escherichia coli

    by Isa Nuryana, Fina Amreta Laksmi, Eva Agustriana, Kartika Sari Dewi, Ade Andriani, Ahmad Thontowi, Wien Kusharyoto, Puspita Lisdiyanti

    Moloney murine leukemia virus reverse transcriptase (MMLV-RT) is the most frequently used enzyme in molecular biology for cDNA synthesis. To date, reverse transcription coupled with Polymerase Chain Reaction, known as RT-PCR, has been popular as an excellent approach for the detection of SARS-CoV-2 during the COVID-19 pandemic. In this study, we aimed to improve the enzymatic production and performance of MMLV-RT by optimizing both codon and culture conditions in E. coli expression system. By applying the optimized codon and culture conditions, the enzyme was successfully overexpressed and increased at high level based on the result of SDS-PAGE and Western blotting. The total amount of MMLV-RT has improved 85-fold from 0.002 g L−1 to 0.175 g L−1 of culture. One-step purification by nickel affinity chromatography has been performed to generate the purified enzyme for further analysis of qualitative and quantitative RT activity. Overall, our investigation provides useful strategies to enhance the recombinant enzyme of MMLV-RT in both production and performance. More importantly, the enzyme has shown promising activity to be used for RT-PCR assay.


  • Production of codon-optimized Human papillomavirus type 52 L1 virus-like particles in Pichia pastoris BG10 expression system

    by Kartika Sari Dewi, Sheila Chairunnisa, Sri Swasthikawati, Yuliawati, Dian Fitria Agustiyanti, Apon Zainal Mustopa, Wien Kusharyoto, Ratih Asmana Ningrum

    Cervical cancer caused by Human papillomavirus (HPV) is one of the most common causes of cancer death in women worldwide. Even though the disease can be avoided by immunization, the expensive price of HPV vaccines makes it hard to be accessed by women in middle-low-income countries. Thus, the development of generic HPV vaccines is needed to address inequalities in life-saving access. This study aimed to develop the HPV52 L1 VLP-based recombinant vaccine using Pichia pastoris expression system. The l1 gene was codon-optimized based on P. pastoris codon usage resulting CAI value of 0.804. The gene was inserted into the pD902 plasmid under the regulation of the AOX1 promoter. The linear plasmid was transformed into P. pastoris BG10 genome and screened in YPD medium containing zeocin antibiotic. Colony of transformant that grown on highest zeocin concentration was characterized by genomic PCR and sequencing. The positive clone was selected and expressed using BMGY/BMMY medium induced with various methanol concentrations. The SDS-PAGE and Western blot analyses showed that 55 kDa L1 protein was successfully expressed using an optimum concentration of 1% methanol. The self-assembly of HPV52 L1 protein was also proven using TEM analysis. Moreover, we also analyzed the B-cell epitope of HPV52 L1 protein based on several criteria, including antigenicity, surface accessibility, flexibility, and hydrophilicity. We assumed that epitope 476GLQARPKLKRPASSAPRTSTKKKKV500 could be developed as an epitope-based vaccine with a neutralizing antibody response toward HPV52 infection. Finally, our study provided the alternative for developing low-cost HPV vaccines, either VLP or epitope-based. Graphical Abstract


  • The Effect of Growth Condition on a Soluble Expression of Anti-EGFRvIII Single-chain Antibody in Escherichia coli NiCo21(DE3)

    by Kartika Sari Dewi, Ratna Annisa Utami, Hariyatun Hariyatun, Riyona Desvy Pratiwi, Dian Fitria Agustiyanti, Asrul Muhamad Fuad

    Kartika Sari Dewi*, Ratna Annisa Utami, Hariyatun Hariyatun, Riyona Desvy Pratiwi , Dian Fitria Agustiyanti, and Asrul Muhamad Fuad. Microbiol. Biotechnol. Lett. 2021;49:1-9. https://doi.org/10.48022/mbl.2006.06004


  • Open Access

    Periplasmic expression of EGFRvIII extracellular domain as a fusion protein in Escherichia coli NiCo21(DE3)

    by K S Dewi, Aminah, A M Fuad

    Epidermal growth factor receptor variant III is a mutant variant of EGFR that has a deletion on its DNA encoding extracellular ligan-binding domain. EGFRvIII is only found in cancer cells and not in normal cells, make it an ideal target as a biomarker for antibody-based cancer therapy. This study performed the expression and characterization of EGFRvIII extracellular domain conjugated with a blue fluorescent protein (BFP) as a fusion protein in Escherichia coli periplasmic space. Endoxylanase signal peptide was employed to guide the recombinant protein through the membrane. IPTG as inducer was added into expression medium with various concentrations of 0; 0.1; 0.25; 0.5; 1 mM, followed by periplasmic extraction using the hypertonic solution. Total proteins and periplasmic proteins were characterized using SDS-PAGE and slot blot analyses. Extracellular domain of EGFRvIII-BFP fusion protein was detected using confocal fluorescence microscopy. This study showed that the ∼43 kDa target protein was successfully expressed on E. coli NiCo21(DE3) periplasmic space with optimum IPTG concentration of 0.1 mM and and showed a blue fluorescence color under the microscope..

  • Open Access

    Strategy for Designing the Synthetic Gene Encoding Human papillomavirus Major Capsid L1 Protein for Heterologous Expression in Escherichia coli System

    by Kartika Sari Dewi, Wien Kusharyoto

    DNA is widely used to construct heterologously expressed genes. The adaptation of the codons to the host organism is necessary in order to ensure sufficient production of proteins. The GC content, codon identity and the mRNA from the translation site are also important in the design of the gene construct. This study performed a strategy for the design of synthetic gene encoding HPV52 L1 protein and several analyses at the genetic level to optimize its protein expression in the Escherichia coli BL21(DE3) host. The determination of the codon optimization was performed by collecting 75 HPV52 L1 protein sequences in the NCBI database. Furthermore, all the sequences were analyzed using multiple global alignments by Clustal Omega web server. Once the model was determined, codon optimization was performed using OPTIMIZER and the web server of the IDT codon optimization tool based on the E. Coli B. The generated open reading frame (ORF) sequence was analyzed using Restriction mapper web server to choose the restriction site for facilitating the cloning stage, which is adjusted for pJExpress414 expression vector. To maximize the protein expression level, the mRNA secondary structure analysis around the ribosome binding site (rbs) was performed. A slight modification at the 5’-terminal end waa carried out in order to get more accessible rbs and increasing mRNA folding free energy. Finally, the construction of the synthetic gene was confirmed to ensure that no mutation occurs in the protein and to calculate its Codon Adaptation Index (CAI) and GC content. The above strategy, which leads to a good ORF sequence with the value of the free mRNA folding energy around rbs, is -5.5 kcal / mol, CAI = 0.787 and GC content 49.5%. This result is much better than its original gene. This result is much better compared to its native gene. Theoretically it is possible that this synthetic gene construct generates a high level protein expression in E. coli BL21 (DE3) under the regulation of the T7 promoter.


  • Open Access

    Expression and characterization of Trichoderma reesei endoglucanase II in Pichia pastoris under the regulation of the GAP promoter

    by Kezia Abib Yerah Tjandra, Kartika Sari Dewi, Asrul Muhamad Fuad, Trisanti Anindyawati

    Trichoderma reesei is known to be one of the organisms capable for producing various types of cellulase in high concentrations. Among these cellulases, the highest catalytic efficiency of endoglucanases II (EGII, EC 3.2.1.4) are considered important for industrial application. The characterization of the EGII is necessary since it is widely used in high-temperature reactions in the industries. In this study, the recombinant EGII protein was expressed in Pichia pastoris and it has a molecular mass of approximately 52 kDa. Recombinant EGII was purified using Ni-NTA affinity chromatography and characterized by SDS-PAGE and western blot analyses. The enzyme activity of recombinant EGII was measured using the Nelson Somogyi method to determine its optimum pH and temperature. The result showed that the maximum EGII expression was achieved after 72 h of culture incubation. The crude enzyme has optimum activity at pH 5.0, resulting in 16.3 U/mL and 14.6 U/mL activity at 40 °C and 50 °C, respectively. While the purified enzyme gave the specific activity of 115.7 U/mg under the optimum condition. Finally, our study demonstrated that recombinant EGII could retain the endoglucanase activity for 89% and 80% at 40 °C and 50 °C, respectively.